-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $35

Benzinga·11/19/2026 18:21:46
Listen to the news
JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.